Yet in another sign that the medical cannabis market is spreading, an Australian medical cannabis and hemp company has recently launched Japan’s first advertising campaign.
The Australian ASX listed company, Elixinol, unleashed their CBD-derived hemp products following a long-fought battle with regulators, Mumbrella reported on Thursday.
Japan is notorious for its anti-marijuana policies. Possession of marijuana is punishable by up to five years in prison.
However, CBD extracted from Hemp was legalized in November 2016. But the CBD derived from marijuana continues to be strictly prohibited.
CBD, the soothing and non-psychoactive cannabinoid, is found in both hemp and marijuana.
Despite hemp’s CBD legalization, companies struggled to gain approval to market their products in Japan.
Elixinol Japan’s CEO Makoto Matsumaru said:
“Japan has a very strong cultural connection with hemp, and its use by our people dates back to ancient times.”
He added: “Elixinol has been supplying hemp oil products to Japan for over three years, however up until now we have not been able to actively market the product range.”
Approval to commercially advertise our Hemp Oil Drops is a major win for the hemp industry and comes after many months of working with the relevant authorities to gain authorization.”
Created by Japanese agency Tsuge Production and Dentsu Tec, the campaign was installed in Tokyo’s Omotesando train station.